ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

19,467Medicare Part D Prescriptions Filled, Including Refills

Rank: 51 out of 680

$1.05M Total Retail Price of All Prescriptions

Rank: 70 out of 680

635 Patients Receiving at Least One Drug in Part D
93%Patients 65 Years and Older
19% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

2% of this provider’s 635 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

13% of this provider’s 635 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

4% of this provider’s 18,329 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

30% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$54 was the average price of a prescription from this provider, compared to $59 among peers.

Prescriptions per Patient

31 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
AMLODIPINE BESYLATE 824 787 1 1
LEVOTHYROXINE SODIUM 636 611 2 2
SIMVASTATIN 631 625 3 3
METOPROLOL SUCCINATE 528 503 4 13
FUROSEMIDE 463 436 5 6
OMEPRAZOLE 435 409 6 7
HYDROCODONE-ACETAMINOPHEN 416 327 S3 7 4
POTASSIUM CHLORIDE 363 351 8 14
LISINOPRIL 317 286 9 5
ZOLPIDEM TARTRATE 311 269 10 17
SERTRALINE HCL 311 307 10 28
HYDROCHLOROTHIAZIDE 294 293 12 9
LOSARTAN POTASSIUM 253 242 13 21
ATENOLOL 253 236 13 19
PRAVASTATIN SODIUM 238 237 15 10
ATORVASTATIN CALCIUM 235 234 16 11
CELEBREX 231 221 17 90
GABAPENTIN 228 189 18 15
RAMIPRIL 226 226 19 69
TAMSULOSIN HCL 220 220 20 34
METFORMIN HCL 212 206 21 8
PANTOPRAZOLE SODIUM 212 204 21 30
WARFARIN SODIUM 200 177 23 20
MELOXICAM 190 187 24 24
METOPROLOL TARTRATE 184 178 25 12
TRAMADOL HCL 183 164 26 18
SYNTHROID 180 180 27 38
CRESTOR 179 157 28 25
CARVEDILOL 175 170 29 23
DIOVAN HCT 170 170 30 55
DIOVAN 167 144 31 31
DONEPEZIL HCL 162 160 32 27
NEXIUM 155 155 33 16
VYTORIN 153 153 34 152
AMITRIPTYLINE HCL 153 136 R 34 47
NAMENDA 152 152 36 35
AMLODIPINE BESYLATE-BENAZEPRIL 146 129 37 43
PREMARIN 145 138 R 38 105
CLONIDINE HCL 137 137 39 36
LOSARTAN-HYDROCHLOROTHIAZIDE 133 133 40 51
BISOPROLOL-HYDROCHLOROTHIAZIDE 125 125 41 156
CLOPIDOGREL 124 113 42 26
CITALOPRAM HBR 123 112 43 22
ACTONEL 123 119 43 213
ESCITALOPRAM OXALATE 109 87 45 45
PREDNISONE 107 107 46 50
CYCLOBENZAPRINE HCL 106 85 R 47 81
CIPROFLOXACIN HCL 106 105 47 57
GLIMEPIRIDE 105 96 49 29
LISINOPRIL-HYDROCHLOROTHIAZIDE 100 100 50 37
AZITHROMYCIN 97 87 51 42
PLAVIX 95 89 52 39
ALENDRONATE SODIUM 93 93 53 32
METFORMIN HCL ER 93 93 53 54
FLUOXETINE HCL 92 83 55 74
TORSEMIDE 89 89 56 163
DIGOXIN 87 83 57 58
GLYBURIDE 85 85 R 58 85
DOXAZOSIN MESYLATE 82 82 59 73
CYMBALTA 81 77 60 46
ESTRADIOL 79 79 R 61 134
FLUTICASONE PROPIONATE 75 74 62 41
INSULIN SYRINGE 74 62 63 86
NIFEDIPINE ER 73 73 64 75
EXELON 72 72 65 112
CLONAZEPAM 70 64 66 190
ZETIA 68 68 67 87
TRIAMTERENE-HCTZ 66 65 68 52
VENLAFAXINE HCL ER 66 48 68 101
RANITIDINE HCL 65 65 70 56
AMIODARONE HCL 64 63 71 158
ACTOS 64 57 71 114
LYRICA 62 60 73 77
EVISTA 61 61 74 135
GLYBURIDE-METFORMIN HCL 61 61 R 74 107
TRAZODONE HCL 61 51 74 48
TEMAZEPAM 60 60 77 155
LANTUS 60 60 77 49
ISOSORBIDE MONONITRATE ER 58 57 79 59
HUMULIN 70-30 56 56 80 277
LEVOFLOXACIN 55 43 81 97
ALLOPURINOL 54 42 82 33
SINGULAIR 53 53 83 91
BUMETANIDE 53 53 83 102
TIZANIDINE HCL 51 50 85 140
BENICAR HCT 51 51 85 150
POLYETHYLENE GLYCOL 3350 50 50 87 62
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 21, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.